Abstract:  IndieBio (http://indiebio.co) is the world’s leading biotechnology accelerator, located in downtown San Francisco. Companies from all over the world apply to be part of a 4 month acceleration program which includes $250,000 funding, dedicated mentorship, and 24/7 access to a co-working space and bio-safety level 1 & 2 labs. During the program, teams are focused on turning science into product, closing customers, raising investment, and developing leadership skills.

With a focus on biology as a technology, IndieBio has funded over 116 companies solving problems in all areas of biotech, including future of food/agriculture, biopharma and healthcare, computational biology, regenerative medicine, neurotech, biomaterials, and more. Some notable alumni: Clara Foods, Memphis Meats, Synthex Therapeutics, Jungla, Catalog, Prellis, Qidni Labs, and Endless West.

Bio:  Dr. Jun Axup is Scientific Director and Partner of IndieBio. She advises companies, runs program operations, makes investment decisions, and builds community. Dr. Axup holds a PhD in chemical biology from The Scripps Research Institute and has worked at several startups in the fields of immuno-oncology, protein engineering, lab automation robotics, CRISPR, and precision medicine. She is passionate about increasing human health span/longevity, hacking brains, and solving climate change.